HIGHLIGHTS
- who: Luca Urso from the Nuclear Medicine Unit, Department of Oncology and Specialist Medicines, University Hospital of Ferrara, Ferrara, Italy have published the research: Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review, in the Journal: (JOURNAL)
- what: The aim of the study are to evaluate safety and efficacy of neoadjuvant RLT followed by surgery in resectable PanNETs at high-risk of recurrence.
- future: Prospective controlled investigations are necessary to confirm these preliminary data and to define the ideal therapeutic scheme. Studies with larger number of cases are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.